Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 29
Filtrar
1.
Int J Cancer ; 146(7): 1950-1962, 2020 04 01.
Artículo en Inglés | MEDLINE | ID: mdl-31376303

RESUMEN

Heme oxygenase 1 (HO-1) plays a pivotal role in preventing cell damage. Indeed, through the antioxidant, antiapoptotic and anti-inflammatory properties of its metabolic products, it favors cell adaptation against different stressors. However, HO-1 induction has also been related to the gain of resistance to therapy in different types of cancers and its involvement in cancer immune-escape has been hypothesized. We have investigated the role of HO-1 expression in Vemurafenib-treated BRAFV600 melanoma cells in modulating their susceptibility to NK cell-mediated recognition. Different cell lines, isolated in house from melanoma patients, have been exposed to 1-10 µM PLX4032, which efficiently reduced ERK phosphorylation. In three lines, Vemurafenib was able to induce only a limited decrease in cell viability, while HO-1 expression was upregulated. HO-1 silencing/inhibition was able to induce a further significant reduction of Vemurafenib-treated melanoma viability. Moreover, while NK cell degranulation and killing activity were decreased upon interaction with melanoma exposed to Vemurafenib, HO-1 silencing was able to completely restore NK cell ability to degranulate and kill. Furthermore, melanoma cell treatment with Vemurafenib downregulated the expression of ligands of NKp30 and NKG2D activating receptors, and HO-1 silencing/inhibition was able to restore their expression. Our results indicate that HO-1 downregulation can both improve the efficacy of Vemurafenib on melanoma cells and favor melanoma susceptibility to NK cell-mediated recognition and killing.


Asunto(s)
Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Hemo-Oxigenasa 1/genética , Células Asesinas Naturales/efectos de los fármacos , Células Asesinas Naturales/metabolismo , Mutación , Proteínas Proto-Oncogénicas B-raf/genética , Vemurafenib/farmacología , Biomarcadores , Línea Celular Tumoral , Citotoxicidad Inmunológica , Silenciador del Gen , Hemo-Oxigenasa 1/metabolismo , Humanos , Inmunofenotipificación , Células Asesinas Naturales/inmunología , Receptores de Células Asesinas Naturales/metabolismo
2.
IUBMB Life ; 65(2): 127-33, 2013 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-23297063

RESUMEN

Besides playing a pathogenic role in Alzheimer disease, amyloid-beta peptides are normally produced in low amounts in the brain, and several lines of evidence suggest that they can modulate synaptic plasticity and memory. As cyclic adenosine monophosphate (cAMP) is known to be involved in the same processes and the blockade of its degradation by phosphodiesterase 4 inhibitors has consistently shown beneficial effects on cognition, we investigated the possible correlation between this second messenger and Aß peptides in neuronal N2a cells overexpressing the amyloid-ß precursor protein (APP). We herein report that the elevation of endogenous cAMP by rolipram increased APP protein expression and both its amyloidogenic and nonamyloidogenic processing. The effects of rolipram were reproduced by both the cAMP membrane-permeant analog 8Br-cAMP and the forskolin-induced activation of adenylyl cyclase but were not affected by the PKA inhibitor H-89. Our results demonstrate that, in neuronal cells, APP metabolism is physiologically modulated by cAMP and suggest that this might represent an additional mechanism through which the second messenger could influence memory functions.


Asunto(s)
Precursor de Proteína beta-Amiloide/metabolismo , AMP Cíclico/fisiología , Procesamiento Proteico-Postraduccional , 8-Bromo Monofosfato de Adenosina Cíclica/farmacología , Adenilil Ciclasas/metabolismo , Precursor de Proteína beta-Amiloide/genética , Animales , Células Cultivadas , Colforsina/farmacología , Activadores de Enzimas/farmacología , Expresión Génica/efectos de los fármacos , Humanos , Ratones , Neuronas/efectos de los fármacos , Neuronas/metabolismo , Inhibidores de Fosfodiesterasa 4/farmacología , Proteolisis , Rolipram/farmacología , Sistemas de Mensajero Secundario
3.
Altern Lab Anim ; 41(6): 491-502, 2013 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-24512233

RESUMEN

The presence of waste in the environment has frequently been indicated as a significant risk to human health. Therefore, landfill sites and the disposal of urban solid and non-hazardous waste by incineration are subject to much environmental monitoring, in addition to the regulations already in place. However, little action has been taken, and consequently no specific legislation exists, in relation to the assessment of the real biological risk of various substances, including chemical mixtures and ashes, derived from the incineration processes. This study assessed the cytotoxic potential of humid lightweight coal ash (LA) derived from incineration processes and waste management, on two cell lines: NCTC 2544 normal human keratinocytes and HECV endothelial cells. To reach this goal and to assess more-realistic methods for animal replacement, we employed different in vitro experimental approaches: acute and longer exposure to LA, by direct and indirect contact (0-2mg/ml and 16mg, respectively), both in 2-D and 3-D cultures. In 2-D HECV cultures, we observed a decrease in the viability index, but only during direct contact with LA doses higher than 0.1mg/ml. Moreover, some striking differences in cytotoxicity were observed between the 2-D and 3-D models. Taken together, these observations indicate that, for studying pollutant toxicity during longer exposure times, 3-D cultures in direct contact with the pollutant seem to offer a more suitable approach - they mimic the in vivo behaviour of cells more realistically and under strictly controlled conditions. Thus, in readiness for possible forthcoming European regulations, we believe that the proposed study, even in its preliminary phase, can provide new advice on the assessment of the toxic and biological potential of particular chemical compounds derived from waste management processes.


Asunto(s)
Ceniza del Carbón/toxicidad , Células Endoteliales/efectos de los fármacos , Queratinocitos/efectos de los fármacos , Células Cultivadas , Humanos , Humedad , Técnicas In Vitro
4.
Int J Mol Sci ; 14(6): 10694-709, 2013 May 23.
Artículo en Inglés | MEDLINE | ID: mdl-23702842

RESUMEN

The aim of this work was to evaluate the ability of oxidative and glycative stressors to modify properties of human serum albumin (HSA) by analyzing markers of glycation (pentosidine) and oxidation (advanced oxidative protein products (AOPPs)) and assessing fluorescence and circular dichroism. HSA was incubated for up to 21 days with ribose, ascorbic acid (AA) and diethylenetriamine pentacetate (DTPA) in various combinations in order to evaluate influences of these substances on the structure of HSA. Ribose was included as a strong glycative molecule, AA as a modulator of oxidative stress, and DTPA as an inhibitor of metal-catalyzed oxidation. Ribose induced a significant increase in pentosidine levels. AA and DTPA prevented the accumulation of pentosidine, especially at later time points. Ribose induced a mild increase in AOPP formation, while AA was a strong inducer of AOPP formation. Ribose, in combination with AA, further increased the formation of AOPP. DTPA prevented the AA-induced generation of AOPP. Ribose was also a potent inducer of fluorescence at 335nm ex/385nm em, which is typical of pentosidine. AA and DTPA prevented this fluorescence. Circular dichroism showed complex results, in which AA and DTPA were strong modifiers of the percentages of the alpha-helical structure of HSA, while ribose affected the structure of HSA only at later time points.


Asunto(s)
Estrés Oxidativo , Albúmina Sérica/química , Albúmina Sérica/metabolismo , Acetatos/farmacología , Arginina/análogos & derivados , Arginina/farmacología , Ácido Ascórbico/farmacología , Dicroismo Circular , Fluorescencia , Glicosilación/efectos de los fármacos , Humanos , Lisina/análogos & derivados , Lisina/farmacología , Oxidación-Reducción/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Estructura Secundaria de Proteína
5.
IUBMB Life ; 64(12): 931-5, 2012 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-23124820

RESUMEN

A large amount of evidence suggests a pathogenic link between cholesterol homeostasis dysregulation and Alzheimer's disease (AD). In cell culture systems, the production of amyloid-ß (Aß) is modulated by cholesterol, and studies on animal models have consistently demonstrated that hypercholesterolemia is associated with an increased deposition of cerebral Aß peptides. Consequently, a number of epidemiological studies have examined the effects of cholesterol-lowering drugs (i.e., statins) in the prevention and the treatment of AD. However, while retrospective studies suggested a potential benefit of statin therapy, clinical trials produced inconsistent results. Here, we summarize the main findings from in vitro and in vivo research where the correlation between cholesterol and the neurodegenerative disorder was investigated. Recognition of this correlation could be an important step forward for our understanding of AD pathogenesis and, possibly, for the development of new therapeutic strategies.


Asunto(s)
Enfermedad de Alzheimer/sangre , Péptidos beta-Amiloides/metabolismo , Corteza Cerebral/metabolismo , Colesterol/sangre , Hipercolesterolemia/sangre , Enfermedad de Alzheimer/complicaciones , Enfermedad de Alzheimer/tratamiento farmacológico , Enfermedad de Alzheimer/patología , Animales , Anticolesterolemiantes/farmacología , Anticolesterolemiantes/uso terapéutico , Corteza Cerebral/efectos de los fármacos , Corteza Cerebral/patología , Ensayos Clínicos como Asunto , Modelos Animales de Enfermedad , Humanos , Inhibidores de Hidroximetilglutaril-CoA Reductasas/farmacología , Inhibidores de Hidroximetilglutaril-CoA Reductasas/uso terapéutico , Hipercolesterolemia/complicaciones , Hipercolesterolemia/tratamiento farmacológico , Hipercolesterolemia/patología , Estudios Retrospectivos
6.
FASEB J ; 23(4): 1246-51, 2009 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-19103644

RESUMEN

A substantial body of evidence indicates that protein kinase C (PKC) is involved in the alpha-secretory processing of the amyloid precursor protein (APP), an event that reduces the formation of the pathogenic amyloid-beta peptide. Recently, we have shown that trafficking and processing of APP are both impaired by knockdown of myosin II-B, one of the major neuronal motor proteins. Here, we provide evidence that the alpha-secretory processing of APP is mediated by PKC-dependent phosphorylation of myosin II-B. This signaling pathway provides an important link between APP and the neuronal cytoskeleton and might be crucial for the understanding of the biological and pathological roles of APP.


Asunto(s)
Precursor de Proteína beta-Amiloide/metabolismo , Miosina Tipo IIB no Muscular/metabolismo , Proteína Quinasa C-alfa/metabolismo , Precursor de Proteína beta-Amiloide/genética , Animales , Línea Celular , Humanos , Cinética , Ratones , Neuronas/metabolismo , Fosforilación , Plásmidos , Interferencia de ARN , Transducción de Señal , Acetato de Tetradecanoilforbol/farmacología , Transfección
7.
Sci Rep ; 10(1): 1358, 2020 Jan 28.
Artículo en Inglés | MEDLINE | ID: mdl-31992816

RESUMEN

We previously demonstrated that cyclic guanosine monophosphate (cGMP) stimulates amyloid precursor protein (APP) and beta-secretase (BACE1) approximation in neuronal endo-lysosomal compartments, thus boosting the production of amyloid-ß (Aß) peptides and enhancing synaptic plasticity and memory. Here, we further investigated the mechanism by which cGMP regulates the subcellular localization of APP and BACE1, finding that the cyclic nucleotide inhibits the activity of Rab5, a small GTPase associated with the plasma membrane and early endosomes. Accordingly, we also found that expression of a dominant-negative Rab5 mutant increases both APP-BACE1 approximation and Aß extracellular levels, therefore mimicking the effects induced by cGMP. These results reveal a functional correlation between the cGMP/Aß pathway and the activity of Rab5 that may contribute to the understanding of Alzheimer's disease pathophysiology.


Asunto(s)
Enfermedad de Alzheimer/metabolismo , Secretasas de la Proteína Precursora del Amiloide/metabolismo , Precursor de Proteína beta-Amiloide/metabolismo , Ácido Aspártico Endopeptidasas/metabolismo , Membrana Celular/metabolismo , Sistemas de Mensajero Secundario , Proteínas de Unión al GTP rab5/metabolismo , Enfermedad de Alzheimer/genética , Enfermedad de Alzheimer/patología , Secretasas de la Proteína Precursora del Amiloide/genética , Precursor de Proteína beta-Amiloide/genética , Animales , Ácido Aspártico Endopeptidasas/genética , Línea Celular , Membrana Celular/genética , Membrana Celular/patología , GMP Cíclico , Endosomas/genética , Endosomas/metabolismo , Endosomas/patología , Ratones , Proteínas de Unión al GTP rab5/genética
8.
Mol Aspects Med ; 29(1-2): 36-42, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18035409

RESUMEN

Protein kinase C (PKC) is a family of isoenzymes differently involved in cell response to injury and many studies describe their role as "stress sensors". Oxidative stress is strictly involved in the pathogenesis of chronic liver diseases including alcohol- or drug-induced hepatotoxicity, iron overload, hepatitis and hepatocarcinoma development, but molecular mechanisms are not really defined. A crucial role of PKC as a redox sensitive signaling molecule has been widely accepted.


Asunto(s)
Hígado/metabolismo , Estrés Oxidativo/fisiología , Proteína Quinasa C/metabolismo , Transducción de Señal , Animales , Humanos , Hígado/patología , Hepatopatías/metabolismo , Hepatopatías/patología , Modelos Biológicos , Especies Reactivas de Oxígeno/metabolismo
9.
Free Radic Biol Med ; 44(3): 474-82, 2008 Feb 01.
Artículo en Inglés | MEDLINE | ID: mdl-17991446

RESUMEN

Glutathione (GSH) depletion is widely used to sensitize cells to anticancer treatment inducing the progression of programmed cell death and overcoming chemoresistance. It has been reported that neuroblastoma cells with MYCN amplification are unable to start TRAIL-dependent death and MYCN, in concert with cytotoxic drugs, efficiently induces the mitochondrial pathway of apoptosis through oxidative mechanisms. In this study, we show that GSH loss induced by L-buthionine-S,R-sulfoximine (BSO), an inhibitor of GSH biosynthesis, leads to overproduction of reactive oxygen species (ROS) and triggers apoptosis of MYCN-amplified neuroblastoma cells. BSO susceptibility of SK-N-BE-2C, a representative example of MYCN-amplified cells, has been attributed to stimulation of total SOD activity in the absence of changes in the level and the activity of catalase. Therefore, the unbalanced intracellular redox milieu has been demonstrated to be critical for the progression of neuroblastoma cell death that was efficiently prevented by antioxidants and rottlerin. These results describe a novel pathway of apoptosis dependent on ROS formation and PKC-delta activation and independent of p53, bcl-2, and bax levels; the selective redox modulation of PKC-delta might be suggested as a potential strategy for sensitizing MYCN-amplified cells to therapeutic approaches.


Asunto(s)
Antineoplásicos/farmacología , Apoptosis , Butionina Sulfoximina/farmacología , Glutatión/antagonistas & inhibidores , Neuroblastoma/metabolismo , Acetofenonas/farmacología , Apoptosis/efectos de los fármacos , Proteínas Reguladoras de la Apoptosis/metabolismo , Ácido Ascórbico/farmacología , Benzopiranos/farmacología , Compuestos de Bifenilo/farmacología , Calpaína/metabolismo , Caspasas/metabolismo , Catalasa/metabolismo , Línea Celular Tumoral , Daño del ADN , Glutatión/metabolismo , Humanos , Proteína Proto-Oncogénica N-Myc , Neuroblastoma/genética , Proteínas Nucleares/genética , Proteínas Oncogénicas/genética , Compuestos Onio/farmacología , Proteína Quinasa C/metabolismo , Especies Reactivas de Oxígeno/metabolismo , Superóxido Dismutasa/metabolismo , Superóxido Dismutasa-1
10.
Front Oncol ; 8: 199, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29951371

RESUMEN

Heme oxygenase 1 (HO-1) is crucially involved in cell adaptation to oxidative stress and has been demonstrated to play an important role in cancer progression and resistance to therapies. We recently highlighted that undifferentiated neuroblastoma (NB) cells are prone to counteract oxidative stress through the induction of HO-1. Conversely, differentiated NB cells were more sensitive to oxidative stress since HO-1 was scarcely upregulated. In this work, we investigated the role played by miR-494, which has been proved to be involved in cancer biology and in the modulation of oxidative stress, in the upregulation of HO-1. We showed that NB differentiation downregulates miR-494 level. In addition, endogenous miR-494 inhibition in undifferentiated cells impairs HO-1 induction in response to exposure to 500 µM H2O2, reducing the number of viable cells. The analysis of Bach1 expression did not reveal any significant modifications in any experimental conditions tested, proving that the impairment of HO-1 induction observed in cells treated with miR-494 inhibitor and exposed to H2O2 is independent from Bach1. Our results underline the role played by miR-494 in favoring HO-1 induction and cell adaptation to oxidative stress and contribute to the discovery of new potential pharmacological targets to improve anticancer therapies.

11.
Mol Aspects Med ; 28(5-6): 591-606, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17306357

RESUMEN

Vitamin E is essential for neurological function. This fact, together with a growing body of evidence indicating that neurodegenerative processes are associated with oxidative stress, lead to the convincing idea that several neurological disorders may be prevented and/or cured by the antioxidant properties of vitamin E. In this review, some aspects related to the role of vitamin E against Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis and ataxia with vitamin E deficiency will be presented.


Asunto(s)
Enfermedades Neurodegenerativas/metabolismo , Enfermedades Neurodegenerativas/prevención & control , Vitamina E/metabolismo , Vitamina E/farmacología , Enfermedad de Alzheimer/metabolismo , Enfermedad de Alzheimer/prevención & control , Esclerosis Amiotrófica Lateral/metabolismo , Esclerosis Amiotrófica Lateral/prevención & control , Animales , Humanos , Enfermedad de Parkinson/metabolismo , Enfermedad de Parkinson/prevención & control , Deficiencia de Vitamina E/metabolismo , Deficiencia de Vitamina E/prevención & control
12.
Brain Res ; 1173: 1-5, 2007 Oct 10.
Artículo en Inglés | MEDLINE | ID: mdl-17803977

RESUMEN

Mounting evidence suggests that peroxisome proliferator-activated receptor-gamma (PPAR-gamma) is involved in the modulation of pathogenic events related to Alzheimer's disease (AD). Such events would include the cerebral deposition of amyloid-beta (Abeta) and the consequent local inflammatory response. PPAR-gamma has been shown to act on both fronts, reducing either the secretion of Abeta or the expression of pro-inflammatory cytokines. Recently, the relatively common Pro12Ala polymorphism in exon 2 of PPAR-gamma has been associated with higher risk for late onset AD. Here, we compare the effect of PPAR-gamma and its genetic variant on the secretion of Abeta. Our results indicate that, in neuronal cultured cells, the Pro12Ala substitution does not affect the anti-amyloidogenic capacity of PPAR-gamma. Additional factors, PPAR-gamma related, may therefore predispose aged subjects, carrying the Ala allele, to develop the neurodegenerative disease.


Asunto(s)
Alanina/genética , Péptidos beta-Amiloides/metabolismo , PPAR gamma/fisiología , Fragmentos de Péptidos/metabolismo , Polimorfismo Genético/fisiología , Animales , Línea Celular Transformada , Clonación Molecular/métodos , Ensayo de Inmunoadsorción Enzimática/métodos , Humanos , Luciferasas/metabolismo , Ratones , Prolina/genética , Transfección/métodos
13.
Neurosci Lett ; 416(3): 261-5, 2007 Apr 18.
Artículo en Inglés | MEDLINE | ID: mdl-17317001

RESUMEN

Advanced glycation end product (AGE) accumulation in brain is believed to contribute to neuronal death in several neurodegenerative diseases. Neurons exposed to AGEs undergo oxidative stress, but the molecular mechanisms able to induce ROS generation and cell death are not yet clear. In this work, we exposed SH-SY5Y neuroblastoma cells to glycated albumin, as a model of AGE-modified protein, and we observed that cells differentiated by retinoic acid died after AGE exposure, through anion superoxide and peroxide generation, while undifferentiated cells resulted resistant. Retinoic acid induced marked increase in p47phox expression and in catalytic activity of PKC delta: the upregulation of a pathway involving NADPH oxidase and PKC delta is likely to be responsible for neuronal susceptibility to AGE. This hypothesis is confirmed by the fact that pre-treatments of differentiated cells with DPI, an inhibitor of NADPH oxidase, or with rottlerin, an inhibitor of PKC delta, were able to prevent AGE-induced neuronal death.


Asunto(s)
Productos Finales de Glicación Avanzada/farmacología , NADPH Oxidasas/metabolismo , Neuronas/efectos de los fármacos , Neuronas/enzimología , Proteína Quinasa C-delta/metabolismo , Análisis de Varianza , Muerte Celular/efectos de los fármacos , Diferenciación Celular/efectos de los fármacos , Línea Celular Tumoral , Relación Dosis-Respuesta a Droga , Interacciones Farmacológicas , Humanos , Proteínas Asociadas a Microtúbulos/metabolismo , Proteínas Quinasas Activadas por Mitógenos/metabolismo , Neuroblastoma/patología , ARN Mensajero/metabolismo , Receptor para Productos Finales de Glicación Avanzada/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Tretinoina/farmacología
14.
Mech Ageing Dev ; 166: 1-5, 2017 09.
Artículo en Inglés | MEDLINE | ID: mdl-28789837

RESUMEN

Long-term potentiation (LTP) and the process of memory formation require activation of cyclic guanosine monophosphate (cGMP) and cyclic adenosine monophosphate (cAMP) pathways. Notably, recent evidence indicated that both cyclic nucleotides boost the production of amyloid-beta (Aß) peptides. In particular, cAMP was shown to favor hippocampal LTP by stimulating the synthesis of the amyloid precursor protein APP, whereas cGMP was found to enhance LTP and to improve memory by increasing Aß levels without affecting the expression of APP. The results of the present study substantiate that cGMP has a role in the endocytic pathway of APP and suggest a scenario where the cyclic nucleotide enhances the production of Aß by favoring the trafficking of APP from the cell cortex to the endolysosomal compartment.


Asunto(s)
Péptidos beta-Amiloides/metabolismo , GMP Cíclico/metabolismo , Endocitosis , Endosomas/metabolismo , Lisosomas/metabolismo , Péptidos beta-Amiloides/genética , Animales , Línea Celular , AMP Cíclico/genética , AMP Cíclico/metabolismo , GMP Cíclico/genética , Endosomas/genética , Potenciación a Largo Plazo , Ratones , Transporte de Proteínas
15.
Antioxidants (Basel) ; 6(2)2017 May 05.
Artículo en Inglés | MEDLINE | ID: mdl-28475131

RESUMEN

The upregulation of heme oxygenase-1 (HO-1) is one of the most important mechanisms of cell adaptation to stress. Indeed, the redox sensitive transcription factor Nrf2 is the pivotal regulator of HO-1 induction. Through the antioxidant, antiapoptotic, and antinflammatory properties of its metabolic products, HO-1 plays a key role in healthy cells in maintaining redox homeostasis and in preventing carcinogenesis. Nevertheless, several lines of evidence have highlighted the role of HO-1 in cancer progression and its expression correlates with tumor growth, aggressiveness, metastatic and angiogenetic potential, resistance to therapy, tumor escape, and poor prognosis, even though a tumor- and tissue-specific activity has been observed. In this review, we summarize the current literature regarding the pro-tumorigenic role of HO-1 dependent tumor progression as a promising target in anticancer strategy.

16.
Biochem J ; 391(Pt 3): 693-8, 2005 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-15946122

RESUMEN

Recent data indicate that PPARgamma (peroxisome proliferator-activated receptor gamma) could be involved in the modulation of the amyloid cascade causing Alzheimer's disease. In the present study we show that PPARgamma overexpression in cultured cells dramatically reduced Abeta (amyloid-beta) secretion, affecting the expression of the APP (Abeta precursor protein) at a post-transcriptional level. APP down-regulation did not involve the pathway of the secretases and correlated with a significant induction of APP ubiquitination. Additionally, we demonstrate that PPARgamma was able to protect the cells from H(2)O(2)-induced necrosis by decreasing Abeta secretion. Taken together, our results indicate a novel mechanism at the basis of the neuroprotection shown by PPARgamma agonists and an additional pathogenic role for Abeta accumulation.


Asunto(s)
Precursor de Proteína beta-Amiloide/metabolismo , PPAR gamma/metabolismo , Procesamiento Proteico-Postraduccional , Enfermedad de Alzheimer/metabolismo , Precursor de Proteína beta-Amiloide/química , Precursor de Proteína beta-Amiloide/genética , Línea Celular , Regulación hacia Abajo , Humanos , Peróxido de Hidrógeno , Necrosis , PPAR gamma/agonistas , Interferencia de ARN
17.
Free Radic Biol Med ; 38(7): 846-56, 2005 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-15749380

RESUMEN

Accumulation of advanced glycation end products (AGEs) induces alterations in the intracellular redox balance, leading cells to functional injury. Current literature reports that intracellular signaling triggered by the interaction of AGEs with their specific receptors RAGEs depends on the cell type and the state of activation/stress. In this work, NT2 human neurons were exposed for 48 h to glycated fetal serum containing 750-3000 pmol/ml pentosidine; the treatment induced an increase in apoptosis rate linear with AGE concentration up to 1500 pmol/ml, but necrotic death was elicited with the highest AGE amount employed (3000 pmol/ml pentosidine). Pentosidine at 1500 pmol/ml, which was the concentration responsible for the highest apoptotic effect (40% of apoptotic neurons), was able to determine early generation of intracellular reactive oxygen species and increase in RAGE levels. Under these conditions, protein kinase C (PKC) delta activity was increased approximately 2-fold, and DNA binding activity of redox-sensitive transcription factor activator protein-1 (AP-1) was enhanced 2.5-fold. A relationship among oxidative stress, PKCdelta activity, AP-1 activation, and apoptosis was demonstrated by pretreating neurons with 500 muM vitamin E, with 20 mug/ml Ginkgo biloba extract, or with 3 muM Rottlerin, inhibitor of PKCdelta; these pretreatments were able to protect neurons from the glycoxidation-dependent effects.


Asunto(s)
Apoptosis , Productos Finales de Glicación Avanzada/metabolismo , Neuronas/enzimología , Estrés Oxidativo/fisiología , Proteína Quinasa C/fisiología , Acetofenonas/farmacología , Antioxidantes/farmacología , Arginina/análogos & derivados , Arginina/farmacología , Benzopiranos/farmacología , Células Cultivadas , Humanos , Lisina/análogos & derivados , Lisina/farmacología , Neuronas/efectos de los fármacos , Oxidación-Reducción , Proteína Quinasa C/antagonistas & inhibidores , Proteína Quinasa C/metabolismo , Proteína Quinasa C-delta , Inhibidores de Proteínas Quinasas/farmacología , Factor de Transcripción AP-1/metabolismo , Vitamina E/farmacología
18.
Mech Ageing Dev ; 152: 1-4, 2015 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-26362724

RESUMEN

For some decades, amyloid ß (Aß) has only been considered as a cytotoxic peptide, putative cause and marker of Alzheimer's disease (AD). Today, however, a considerable amount of evidence goes against the classical amyloid hypothesis and illustrates a new picture in which the Aß loss of function, rather than its accumulation, has a pathogenic role in AD. In this concise review, we summarize some highlights of a collection of research pointing to the physiological function of Aß and its role in the mechanisms of memory formation.


Asunto(s)
Enfermedad de Alzheimer/metabolismo , Péptidos beta-Amiloides/metabolismo , Memoria , Enfermedad de Alzheimer/patología , Enfermedad de Alzheimer/fisiopatología , Animales , Humanos
19.
Free Radic Biol Med ; 36(8): 1018-24, 2004 Apr 15.
Artículo en Inglés | MEDLINE | ID: mdl-15059642

RESUMEN

Scavenger receptors recently have been related to Alzheimer's disease, although it is still unclear whether they contribute to the pathogenesis of the disease or reflect an inflammatory response to the deposition of amyloid beta-protein (Abeta). In this study we demonstrate that CD36, a class B scavenger receptor, is highly expressed in the cerebral cortex of Alzheimer's disease patients and cognitively normal aged subjects with diffuse amyloid plaques compared with age-matched amyloid-free control brains. Moreover, in vitro experiments indicated that Abeta is able to induce CD36 expression in neuronal cells after 24 h treatment. The interaction between CD36 and Abeta has been reported to trigger oxidant production by macrophages and microglia. In line with this observation, we found an increased presence of nitrated proteins in brains showing Abeta loads and CD36 overexpression, independent of the occurrence of Alzheimer's disease pathologic features.


Asunto(s)
Enfermedad de Alzheimer/metabolismo , Péptidos beta-Amiloides/metabolismo , Péptidos beta-Amiloides/fisiología , Encéfalo/metabolismo , Antígenos CD36/biosíntesis , Fragmentos de Péptidos/fisiología , Anciano , Anciano de 80 o más Años , Encéfalo/patología , Antígenos CD36/metabolismo , Radicales Libres , Lóbulo Frontal/metabolismo , Células HL-60 , Humanos , Immunoblotting , Macrófagos/metabolismo , Monocitos/metabolismo , Neuroglía/metabolismo , Neuronas/metabolismo , Oxidantes/metabolismo , Estrés Oxidativo , ARN Mensajero/metabolismo , Receptores Inmunológicos/metabolismo , Receptores Depuradores , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Receptores Depuradores de Clase B , Factores de Tiempo
20.
Biochem Pharmacol ; 66(8): 1521-6, 2003 Oct 15.
Artículo en Inglés | MEDLINE | ID: mdl-14555230

RESUMEN

Current evidence demonstrates that protein kinase C (PKC) belongs to a group of cell-signaling molecules that are sensitive targets for redox modifications and functional alterations that mediate oxidant-induced cellular responses. Our studies have demonstrated that diminished intracellular GSH was associated to inactivation of classic isoforms and increased activity of novel PKCs, and triggered molecular signals important for cell survival. Loss of GSH and oxidative damage are probably an early signaling event in apoptotic death, which is characterized by the activation of PKC-delta. Apoptotic process consequent to GSH depletion was inhibited by rottlerin, a PKC-delta-specific inhibitor, which exerted a negative effect on oxyradical production. Therefore, it may be concluded that PKC-delta activity is related to reactive oxygen species production and is involved in the pathway leading to apoptosis and growth arrest.


Asunto(s)
Apoptosis/fisiología , Glutatión/metabolismo , Proteína Quinasa C/fisiología , Acetofenonas/farmacología , Animales , Benzopiranos/farmacología , Células Cultivadas , Glutatión/deficiencia , Proteína Quinasa C-delta , Ratas , Especies Reactivas de Oxígeno/metabolismo , Transducción de Señal/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA